Kamila Naxerova, Ph.D.
Affiliations: | 2014 | Biology: Medical Sciences, Division of | Harvard University, Cambridge, MA, United States |
Area:
Genetics, OncologyGoogle:
"Kamila Naxerova"Parents
Sign in to add mentor| Rakesh K. Jain | grad student | 2014 | Harvard | |
| (Tracing human cancer evolution with hypermutable DNA.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Burr R, Leshchiner I, Costantino CL, et al. (2023) Germline mutations and developmental mosaicism underlying -mutant lung cancer. Medrxiv : the Preprint Server For Health Sciences |
| Datta M, Chatterjee S, Perez EM, et al. (2023) Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse models. Proceedings of the National Academy of Sciences of the United States of America. 120: e2219199120 |
| Ferraro GB, Ali A, Luengo A, et al. (2022) Author Correction: Fatty acid synthesis is required for breast cancer brain metastasis. Nature Cancer. 2: 1243 |
| Ferraro GB, Ali A, Luengo A, et al. (2021) FATTY ACID SYNTHESIS IS REQUIRED FOR BREAST CANCER BRAIN METASTASIS. Nature Cancer. 2: 414-428 |
| Chen IX, Newcomer K, Pauken KE, et al. (2020) A bilateral tumor model identifies transcriptional programs associated with patient response to immune checkpoint blockade. Proceedings of the National Academy of Sciences of the United States of America |
| Naxerova K. (2020) Defining the role of lymph node metastasis in systemic breast cancer evolution. Ebiomedicine. 57: 102852 |
| Heyde A, Reiter JG, Naxerova K, et al. (2019) Consecutive seeding and transfer of genetic diversity in metastasis. Proceedings of the National Academy of Sciences of the United States of America |
| Chauhan VP, Chen IX, Tong R, et al. (2019) Reprogramming the microenvironment with tumor-selective angiotensin blockers enhances cancer immunotherapy. Proceedings of the National Academy of Sciences of the United States of America |
| Talele NP, Liu H, Naxerova K, et al. (2019) Abstract A115: Use of angiotensin system inhibitors is associated with immune activation and longer survival in pancreatic ductal adenocarcinoma patients Cancer Immunology Research. 7 |
| Liu H, Ho WW, Naxerova K, et al. (2019) Abstract A18: Angiotensin receptor blockers normalize the pancreatic ductal adenocarcinoma stroma by reprogramming carcinoma-associated fibroblasts Cancer Research. 79 |